Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm microtubule inner protein 8 (SPMIP8) is a cytoskeletal protein specifically expressed in testis, prostate, and placenta, and conserved across chordate species[1][2][3][4][8]. It is localized to the flagellum axoneme of sperm, where it serves as a microtubule inner protein (MIP), possibly reinforcing and stabilizing the doublet microtubules in the axoneme and supporting motile cilium function[2][9]. Scientifically, SPMIP8 is a protein-coding gene with tissue-restricted expression suggestive of specialized roles in the structural integrity and motility of sperm flagella. Its expression is selective to reproductive tissues and it may contribute to reproductive biology, but current evidence does not support a specific enzymatic, receptor, or transport function[1][2][4][8]. There are no disease-modifying or therapeutic roles established for SPMIP8, nor are there direct pharmacological modulators, clinical biomarkers, or safety challenges documented in the literature.
Not applicable. No mechanism of action for drugs targeting SPMIP8 is known or characterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm microtubule inner protein 8 (SPMIP8).